CCL2 and neoplasm: Recently, we showed that the protein expression of the chemokine CCL2 (monocyte chemotactic protein 1/MCP-1) in tumor cells (TCs) was an independent negative prognostic factor for overall survival (OS), but its expression in immune cells (ICs) was an independent positive prognostic factor for disease-specific survival (DSS) in MIBC patients [18].